Innate Pharma
IPHA
#8313
Rank
โ‚ฌ0.16 B
Marketcap
1,98ย โ‚ฌ
Share price
-1.90%
Change (1 day)
-17.98%
Change (1 year)

Market capitalization of Innate Pharma (IPHA)

Market cap: โ‚ฌ0.16 Billion

As of December 2024 Innate Pharma has a market cap of โ‚ฌ0.16 Billion. This makes Innate Pharma the world's 8313th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Innate Pharma from 2006 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚ฌ0.16 B-21.34%
2023โ‚ฌ0.20 B-25.33%
2022โ‚ฌ0.27 B-21.15%
2021โ‚ฌ0.35 B29.36%
2020โ‚ฌ0.27 B-41.78%
2019โ‚ฌ0.46 B-1.32%
2018โ‚ฌ0.47 B75.35%
2017โ‚ฌ0.27 B-65.69%
2016โ‚ฌ0.79 B8.59%
2015โ‚ฌ0.72 B74.24%
2014โ‚ฌ0.41 B84.47%
2013โ‚ฌ0.22 B175.41%
2012โ‚ฌ82.3 M107.75%
2011โ‚ฌ39.61 M-9.82%
2010โ‚ฌ43.93 M-51.52%
2009โ‚ฌ90.62 M154.49%
2008โ‚ฌ35.6 M-43.41%
2007โ‚ฌ62.92 M-41.87%
2006โ‚ฌ0.10 B

End of Day market cap according to different sources

On Dec 23rd, 2024 the market cap of Innate Pharma was reported to be:

โ‚ฌ0.16 Billion
by Nasdaq info icon info icon
โ‚ฌ0.17 Billion
by CompaniesMarketCap info icon info icon